Rize Oncology Inc.
Rize Oncology Inc.
CSE Index:
CSE CompositeCurrency:
CAD Rize Oncology Inc. is a pharmaceutical company dedicated to developing innovative oncology therapies. With a focus on advancing treatments for soft tissue sarcoma, Rize Oncology aims to make a meaningful impact on patients' lives by Turning the Tide on Metastasis.
Rize Oncology Inc. (RIZE)
0.03
0.00 (0.00%)
Rize Oncology Inc. (RIZE)
*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.
Bid Size
22,000
Bid Price
0.02
Ask Price
0.05
Ask Size
9,000
Volume
0
Last Price
0.03
Tick
Net Change
Prev Close
0.03
Open
0.00
Day High
0.00
Day Low
0.00
52 Week High
0.15
52 Week Low
0.015
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
0
Bid Price
0.00
Ask Price
0.00
Ask Size
0
Volume
0
Last Price
Tick
Net Change
Prev Close
Open
0.00
Day High
0.00
Day Low
0.00
52 Week High
52 Week Low
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
22,000
Bid Price
0.02
Ask Price
0.05
Ask Size
9,000
Volume
0
Last Price
0.03
Tick
Net Change
Prev Close
0.03
Open
0.00
Day High
0.00
Day Low
0.00
52 Week High
0.15
52 Week Low
0.015
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
0
Bid Price
0.00
Ask Price
0.00
Ask Size
0
Volume
0
Last Price
Tick
Net Change
Prev Close
Open
0.00
Day High
0.00
Day Low
0.00
52 Week High
52 Week Low
*Note: Bid Size and Ask Size fields are displayed as actual quantities
| Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
|---|---|---|---|---|---|
| CIBC World Markets Inc. | 2,000 | 0.02 | 0.05 | 5,000 | Desjardins Securities Inc. |
| National Bank Financial Inc. | 10,000 | 0.02 | 0.05 | 4,000 | CIBC World Markets Inc. |
| Desjardins Securities Inc. | 10,000 | 0.02 | 0.06 | 5,000 | Desjardins Securities Inc. |
| TD Securities Inc. | 200,000 | 0.005 | 0.08 | 5,000 | National Bank Financial Inc. |
| 0 | 0.00 | 0.12 | 10,000 | Scotia Capital Inc. | |
| 0 | 0.00 | 0.43 | 2,000 | RBC Capital Markets | |
| 0 | 0.00 | 0.50 | 2,000 | Scotia Capital Inc. | |
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 |
| Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
|---|---|---|---|---|---|
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 |
| Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
|---|---|---|---|---|---|
| 3 | 22,000 | 0.02 | 0.05 | 9,000 | 2 |
| 1 | 200,000 | 0.005 | 0.06 | 5,000 | 1 |
| 0 | 0 | 0.00 | 0.08 | 5,000 | 1 |
| 0 | 0 | 0.00 | 0.12 | 10,000 | 1 |
| 0 | 0 | 0.00 | 0.43 | 2,000 | 1 |
| Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
|---|---|---|---|---|---|
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| Date/Time | Price | Change | Volume | Buyer | Seller | Venue |
|---|---|---|---|---|---|---|
| Apr 24, 19:46 | 0.03 | 0.00 | 10,000 | Desjardins Securities Inc. | CIBC World Markets Inc. | CSE |
| Apr 24, 19:44 | 0.02 | -0.01 | 4,000 | CIBC World Markets Inc. | TD Securities Inc. | CSE |
| Apr 24, 19:08 | 0.03 | 0.00 | 1,000 | RBC Capital Markets | CIBC World Markets Inc. | CSE |
| Apr 23, 15:19 | 0.04 | 0.01 | 5,000 | National Bank Financial Inc. | CIBC World Markets Inc. | CSE |
| Apr 23, 14:13 | 0.04 | 0.01 | 4,000 | TD Securities Inc. | CIBC World Markets Inc. | CSE |
Company Info
Address
301-1665 Ellis Street
Kelowna, BC V1Y 2B3
CanadaPhone
(514) 796-2640Email
Roland@genetether.comWebsite
https://www.rizeoncology.comListing date
Monday, March 28, 2022Transfer Agent
Odyssey Trust CompanySEDAR Information
Filing Type
Any
News Releases
Material Change Report
Management's Discussion & Analysis
Financial Statements
Timeframe
1 week1 month3 month6 month1 yearAll Time
Rize Oncology Inc.
Date:
Mar 28, 2024
Rize Oncology Inc.
Date:
Mar 28, 2024
Rize Oncology Inc.
Date:
Apr 27, 2023
Rize Oncology Inc.
Date:
Apr 27, 2023
Rize Oncology Inc.
Date:
Apr 28, 2022
Rize Oncology Inc.
Date:
Mar 30, 2022
Rize Oncology Inc.
Date:
Mar 21, 2022
Rize Oncology Inc.
Date:
Mar 21, 2022
Rize Oncology Inc.
Date:
Mar 21, 2022
Rize Oncology Inc.
Date:
Mar 21, 2022
Rize Oncology Inc.
Date:
Jan 27, 2022
Rize Oncology Inc.
Date:
Nov 5, 2021
Rize Oncology Inc.
Date:
Nov 5, 2021
Rize Oncology Inc.
Date:
Nov 5, 2021
Company Info
Address
301-1665 Ellis Street
Kelowna, BC V1Y 2B3
CanadaPhone
(514) 796-2640Email
Roland@genetether.comWebsite
https://www.rizeoncology.comListing date
Monday, March 28, 2022Transfer Agent
Odyssey Trust CompanyCapitalization
Issued & Outstanding:
75744674Reserved for Issuance:
17942855Company Officers
Roland Boivin, Chief Executive Officer
Daren Graham, Chairman
James O'Neill, Chief Financial Officer
John Rothman, Chief Scientific Officer
Bulletins
10/01/2025
2025-0106– Name and Symbol Change - GeneTether Therapeutics Inc. (GTTX)
le 10 janvier/January 2025
GeneTether Therapeutics Inc. (GTTX) has announced a name and symbol change to Rize Oncology Inc. (RIZE)
Shares will begin trading under the new name and symbol and with a new CUSIP number on January 13, 2025.
Disclosure documents are available at www.thecse.com.
